Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection
Persistent high-risk human papillomavirus (hrHPV) infection is the highest risk to cervical cancer which is the fourth most common cancer in women worldwide. A growing body of literatures demonstrate the role of cervicovaginal microbiome (CVM) in hrHPV susceptibility and clearance, suggesting the pr...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.722639/full |
id |
doaj-2670bdd0307d451fb965bad56a7bfa37 |
---|---|
record_format |
Article |
spelling |
doaj-2670bdd0307d451fb965bad56a7bfa372021-07-28T10:15:38ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-07-011110.3389/fonc.2021.722639722639Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus InfectionWenkui Dai0Wenkui Dai1Wenkui Dai2Hui Du3Hui Du4Hui Du5Shuaicheng Li6Ruifang Wu7Ruifang Wu8Ruifang Wu9Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen, ChinaInstitute of Obstetrics and Gynecology, Shenzhen Peking University-The Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Shenzhen, ChinaShenzhen Key Laboratory on Technology for Early Diagnosis of Major Gynecologic Diseases, Shenzhen, ChinaDepartment of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen, ChinaInstitute of Obstetrics and Gynecology, Shenzhen Peking University-The Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Shenzhen, ChinaShenzhen Key Laboratory on Technology for Early Diagnosis of Major Gynecologic Diseases, Shenzhen, ChinaDepartment of Biomedical Engineering, City University of Hong Kong, Hong Kong, ChinaDepartment of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen, ChinaInstitute of Obstetrics and Gynecology, Shenzhen Peking University-The Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Shenzhen, ChinaShenzhen Key Laboratory on Technology for Early Diagnosis of Major Gynecologic Diseases, Shenzhen, ChinaPersistent high-risk human papillomavirus (hrHPV) infection is the highest risk to cervical cancer which is the fourth most common cancer in women worldwide. A growing body of literatures demonstrate the role of cervicovaginal microbiome (CVM) in hrHPV susceptibility and clearance, suggesting the promise of CVM-targeted interventions in protecting against or eliminating HPV infection. Nevertheless, the CVM-HPV-host interactions are largely unknown. In this review, we summarize imbalanced CVM in HPV-positive women, with or without cervical diseases, and the progress of exploring CVM resources in HPV clearance. In addition, microbe- and host-microbe interactions in HPV infection and elimination are reviewed to understand the role of CVM in remission of HPV infection. Lastly, the feasibility of CVM-modulated and -derived products in promoting HPV clearance is discussed. Information in this article will provide valuable reference for researchers interested in cervical cancer prevention and therapy.https://www.frontiersin.org/articles/10.3389/fonc.2021.722639/fullcervical cancerhigh-risk HPVCVM-targeted interventionCVM-derived productHPV clearance |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wenkui Dai Wenkui Dai Wenkui Dai Hui Du Hui Du Hui Du Shuaicheng Li Ruifang Wu Ruifang Wu Ruifang Wu |
spellingShingle |
Wenkui Dai Wenkui Dai Wenkui Dai Hui Du Hui Du Hui Du Shuaicheng Li Ruifang Wu Ruifang Wu Ruifang Wu Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection Frontiers in Oncology cervical cancer high-risk HPV CVM-targeted intervention CVM-derived product HPV clearance |
author_facet |
Wenkui Dai Wenkui Dai Wenkui Dai Hui Du Hui Du Hui Du Shuaicheng Li Ruifang Wu Ruifang Wu Ruifang Wu |
author_sort |
Wenkui Dai |
title |
Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection |
title_short |
Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection |
title_full |
Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection |
title_fullStr |
Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection |
title_full_unstemmed |
Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection |
title_sort |
cervicovaginal microbiome factors in clearance of human papillomavirus infection |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2021-07-01 |
description |
Persistent high-risk human papillomavirus (hrHPV) infection is the highest risk to cervical cancer which is the fourth most common cancer in women worldwide. A growing body of literatures demonstrate the role of cervicovaginal microbiome (CVM) in hrHPV susceptibility and clearance, suggesting the promise of CVM-targeted interventions in protecting against or eliminating HPV infection. Nevertheless, the CVM-HPV-host interactions are largely unknown. In this review, we summarize imbalanced CVM in HPV-positive women, with or without cervical diseases, and the progress of exploring CVM resources in HPV clearance. In addition, microbe- and host-microbe interactions in HPV infection and elimination are reviewed to understand the role of CVM in remission of HPV infection. Lastly, the feasibility of CVM-modulated and -derived products in promoting HPV clearance is discussed. Information in this article will provide valuable reference for researchers interested in cervical cancer prevention and therapy. |
topic |
cervical cancer high-risk HPV CVM-targeted intervention CVM-derived product HPV clearance |
url |
https://www.frontiersin.org/articles/10.3389/fonc.2021.722639/full |
work_keys_str_mv |
AT wenkuidai cervicovaginalmicrobiomefactorsinclearanceofhumanpapillomavirusinfection AT wenkuidai cervicovaginalmicrobiomefactorsinclearanceofhumanpapillomavirusinfection AT wenkuidai cervicovaginalmicrobiomefactorsinclearanceofhumanpapillomavirusinfection AT huidu cervicovaginalmicrobiomefactorsinclearanceofhumanpapillomavirusinfection AT huidu cervicovaginalmicrobiomefactorsinclearanceofhumanpapillomavirusinfection AT huidu cervicovaginalmicrobiomefactorsinclearanceofhumanpapillomavirusinfection AT shuaichengli cervicovaginalmicrobiomefactorsinclearanceofhumanpapillomavirusinfection AT ruifangwu cervicovaginalmicrobiomefactorsinclearanceofhumanpapillomavirusinfection AT ruifangwu cervicovaginalmicrobiomefactorsinclearanceofhumanpapillomavirusinfection AT ruifangwu cervicovaginalmicrobiomefactorsinclearanceofhumanpapillomavirusinfection |
_version_ |
1721278758764150784 |